The SURMOUNT trials showed tirzepatide at 15 mg achieving 15% to 21% weight loss by week 72, compared to semaglutide at 2.4 mg achieving approximately 15% by week 68
Yu R, Schellhorn HE
Implications for employers: - This demonstrates that two of the GLP-1 drugs (tirzepatide and semaglutide, both injectable) are associated with much more weight loss than even especially effective diets
C.MoralesC.et al
Goat Anti-Mouse IgG H&L Alexa Fluor 594, Abcam, ab150116) diluted in 1% BSA in PBST for 1 h at room temperature
doi: 10.1016/j.ajog.2020.06.004 Summary Keywords endometriosis, infertility, hormonal dysregulation, immune dysfunction, oxidative stress, microbiome, therapeutic strategies Citation Ou Y, Wang H, Zhou C, Chen Y, Lyu J, Feng M and Huang X (2025) Endometriosis-associated infertility: Multi-omics insights into pathogenesis and precision therapeutics